Precision Immune Monitoring: a new standard in immuno-oncology

  • Uncover antigen-specific immune cells: Probe a range of immune cells including antigen-specific CD8+ and CD4+ T cells, MAIT cells, NKT cells, B Cells, Antigen-presenting cells and CAR-T cells.

  • Granular insights: An extensive menu of alleles and epitopes, and the unmatched avidity of Dextramer®-based reagents, reveal rare and low-affinity cell subsets that go undetected by other multimers.

  • Consistent performance: Time-tested Dextramer® technology performs consistently and reliably so you can count on reproducible and comparable results.

  • Full-spectrum characterization: Don’t stop at one epitope. We’ve developed predefined Dextramer® panels for 6 melanoma-associated antigens and for cancer-testis antigens. Alternatively, explore our list of published cancer epitopes for human or mouse, or talk with our experts to develop custom solutions tailored to your needs.

Let's Talk Science

Get in Touch with our Immune Monitoring Experts

Advance your immuno-oncology research with deep insights into immune responses. Dextramer® reagents facilitate immunity-informed decisions in cancer research and treatments with highly sensitive detection, quantification, and isolation of antigen-specific immune cell populations. Our reagents unravel the complexity of the immune response for a more comprehensive immune monitoring that identifies even rare or low-affinity immune cells, and offers a precise means to understand the kinetics of immune cells in the fight against cancer.

"Most current FDA-approved and investigational immunotherapies for cancer are designed to augment, activate, or replace antigen-specific T-cell immunity.

The ability to experimentally detect antigen-specific responses in T cells is a critical readout in demonstrating efficacy and investigating side effects of these treatments."

- Scientist, Pharmaceutical Company
“As a company that develops targeted immunotherapies, we have used Dextramer® reagents in our preclinical development and clinical trials. Based on this, we view Immudex as a reliable partner and can attest to the consistent quality they provide.”

- Kerry Sieger, M.A. Senior Director Global Quality Operations, Immatics

Get the full picture of the cellular immune response with Dextramer®

Questions? Let's Talk Science!

Get in touch with our immune monitoring experts